UDI: Value Beyond Compliance
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.
Related Resources
Issue Brief
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
White Papers
A recap of the Executive Thought Leader Forum hosted by AHRMM on August 6, 2012, to discuss the transforming healthcare environment.
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Advisory
The FDA UDI ruling has finally arrived - the proposed rule has published.